Get all your news in one place.
100's of premium titles.
One app.
Start reading
The Conversation
The Conversation
Michael Head, Senior Research Fellow in Global Health, University of Southampton

What happened to the AstraZeneca vaccine? Now rare in rich countries, it’s still saving lives around the world

PhotobyTawat/Shutterstock

The AstraZeneca vaccine, developed in partnership with the University of Oxford, was one of the first vaccines available for use in the UK and around the world during the COVID pandemic.

More than two billion doses have been distributed to at least 170 countries, with around 50 million doses administered in the UK.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.